MX2020004425A - Síntesis de derivados de éster boronato y usos de estos. - Google Patents

Síntesis de derivados de éster boronato y usos de estos.

Info

Publication number
MX2020004425A
MX2020004425A MX2020004425A MX2020004425A MX2020004425A MX 2020004425 A MX2020004425 A MX 2020004425A MX 2020004425 A MX2020004425 A MX 2020004425A MX 2020004425 A MX2020004425 A MX 2020004425A MX 2020004425 A MX2020004425 A MX 2020004425A
Authority
MX
Mexico
Prior art keywords
synthesis
ester derivatives
boronate ester
formula
methods
Prior art date
Application number
MX2020004425A
Other languages
English (en)
Inventor
Scott J Hecker
Serge Henri Boyer
Gerardus K M Verzijl
Petrus J Hermsen
Original Assignee
Melinta Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melinta Therapeutics Inc filed Critical Melinta Therapeutics Inc
Publication of MX2020004425A publication Critical patent/MX2020004425A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/46—Ruthenium, rhodium, osmium or iridium
    • B01J23/462—Ruthenium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/31—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/02—Boron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/02—Boron compounds
    • C07F5/04—Esters of boric acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/002—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by oxidation/reduction reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen

Abstract

En la presente descripción se describen los métodos para la preparación de derivados de boronato en la síntesis de compuestos antimicrobianos y sus usos. En la presente descripción se describen los métodos para preparar un compuesto de la Fórmula (B) mediante la reducción del grupo cetona del compuesto cetoéster de la Fórmula (A), y la reducción puede realizarse mediante el uso de un sistema catalítico que se basa en Rutenio o mediante el uso de un sistema de biorreducción de la alcohol deshidrogenasa.
MX2020004425A 2017-11-01 2018-10-30 Síntesis de derivados de éster boronato y usos de estos. MX2020004425A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762580343P 2017-11-01 2017-11-01
PCT/US2018/058143 WO2019089542A1 (en) 2017-11-01 2018-10-30 Synthesis of boronate ester derivatives and uses thereof

Publications (1)

Publication Number Publication Date
MX2020004425A true MX2020004425A (es) 2020-08-06

Family

ID=66245250

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2020004425A MX2020004425A (es) 2017-11-01 2018-10-30 Síntesis de derivados de éster boronato y usos de estos.
MX2023000529A MX2023000529A (es) 2017-11-01 2020-07-13 Sintesis de derivados de ester boronato y usos de estos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2023000529A MX2023000529A (es) 2017-11-01 2020-07-13 Sintesis de derivados de ester boronato y usos de estos.

Country Status (15)

Country Link
US (2) US20200308197A1 (es)
EP (1) EP3704130A4 (es)
JP (1) JP2021501205A (es)
KR (1) KR20200076730A (es)
CN (1) CN111556872A (es)
AU (1) AU2018360502A1 (es)
BR (1) BR112020008498A2 (es)
CA (1) CA3080763A1 (es)
CL (1) CL2020001143A1 (es)
CO (1) CO2020006299A2 (es)
JO (1) JOP20200101A1 (es)
MX (2) MX2020004425A (es)
PH (1) PH12020550544A1 (es)
SG (1) SG11202003762VA (es)
WO (1) WO2019089542A1 (es)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783443A (en) 1986-03-03 1988-11-08 The University Of Chicago Amino acyl cephalosporin derivatives
DE10119274A1 (de) * 2001-04-20 2002-10-31 Juelich Enzyme Products Gmbh Enzymatisches Verfahren zur enantioselektiven Reduktion von Ketoverbindungen
EP1386901B1 (en) * 2002-07-30 2015-07-01 Takasago International Corporation Method for producing an optically active beta-amino acid
DE102004022397A1 (de) * 2004-05-06 2005-12-01 Consortium für elektrochemische Industrie GmbH Chirale C2-symmetrische Biphenyle, deren Herstellung sowie Metallkomplexe enthaltend diese Liganden und deren Verwendung als Katalysatoren in chirogenen Synthesen
WO2007034909A1 (ja) * 2005-09-22 2007-03-29 Kaneka Corporation （３ｒ，５ｒ）－７－アミノ－３，５－ジヒドロキシヘプタン酸誘導体の製造法
CN103180328B (zh) * 2010-08-10 2016-10-26 莱姆派克斯制药公司 环硼酸酯衍生物及其治疗用途
WO2013056163A1 (en) * 2011-10-14 2013-04-18 The Regents Of The University Of California Beta-lactamase inhibitors
WO2013122888A2 (en) * 2012-02-15 2013-08-22 Rempex Pharmaceuticals, Inc. Methods of treating bacterial infections
US9422314B2 (en) * 2012-12-07 2016-08-23 VenatoRx Pharmaceuticals, Inc. Beta-lactamase inhibitors
HUE046836T2 (hu) * 2014-05-05 2020-03-30 Rempex Pharmaceuticals Inc Boronát sók szintézise és alkalmazásuk

Also Published As

Publication number Publication date
CN111556872A (zh) 2020-08-18
JP2021501205A (ja) 2021-01-14
CL2020001143A1 (es) 2020-10-30
KR20200076730A (ko) 2020-06-29
JOP20200101A1 (ar) 2022-10-30
CA3080763A1 (en) 2019-05-09
US20190127396A1 (en) 2019-05-02
SG11202003762VA (en) 2020-05-28
MX2023000529A (es) 2023-02-13
US20200308197A1 (en) 2020-10-01
PH12020550544A1 (en) 2021-03-22
BR112020008498A2 (pt) 2020-10-20
EP3704130A1 (en) 2020-09-09
AU2018360502A1 (en) 2020-06-04
WO2019089542A1 (en) 2019-05-09
EP3704130A4 (en) 2021-07-07
CO2020006299A2 (es) 2020-06-09

Similar Documents

Publication Publication Date Title
UY38070A (es) Derivados de quinazolina y piridopirimidina sustituidos útiles como agentes anticáncer
UY38076A (es) Derivados de tetrahidroquinazolina útiles como agentes anticáncer
DOP2019000165A (es) Anticuerpos anti-ox40 y sus usos
DOP2018000268A (es) Derivados de carbonucleósidos sustituidos útiles como agentes antineoplásicos
CL2017001675A1 (es) Derivados de quinazolina utilizados para tratar el vih
BR112017009601A2 (pt) derivados de aminoácidos e seus usos
BR112018072246A2 (pt) síntese de indazóis
AR093244A1 (es) Compuestos de benceno sustituidos utilizables en el tratamiento de trastornos mediados por ezh2
BR112016000489A8 (pt) composto, composição farmacêutica que o compreende, uso da composição e métodos para fabricar compostos
CU24272B1 (es) Derivados de tetrahidropirido-pirimidina como inhibidores de mek
PE20142456A1 (es) COMPUESTOS DE OXAZOLIDIN-2-ONA Y USOS DE LOS MISMOS COMO INHIBIDORES DE LA PI3Ks
AR094964A1 (es) USO DE DERIVADOS DE PIRAZOLOPIRIMIDINA PARA EL TRATAMIENTO DE TRASTORNOS RELACIONADOS CON LA FOSFOINOSITIDA 3-CINASA d (PI3Kd)
ECSP10010496A (es) Derivado heterociclico fusionado y su uso
CO2019012957A2 (es) Inhibidores de quinasa y usos de los mismos
GT200600394A (es) Benzimidazoles sustituidos y metodos para usarlos como inhibidores de las quinasas asociadas con la tumorigenesis.
UY37015A (es) Inhibidores de la tirosina quinasa de bruton y métodos de su uso
DOP2016000047A (es) Compuestos y composiciones como inhibidores de la mek
AR103077A1 (es) Método para la producción de un sistema de administración farmacéutica
UY37016A (es) Inhibidores de la tirosina quinasa de bruton y métodos de su uso
DOP2016000308A (es) Compuestos de 1, 3, 4-tiadiazol y uso de los mismos para el tratamiento del cáncer
UY36195A (es) Amidas de benzoxazinona como reguladores del receptor mineralocorticoide
CL2018003121A1 (es) Inhibidores del potenciador del homólogo zeste 2.
CY1122423T1 (el) Παραγωγα πυριμιδινης χρησιμα ως εκλεκτικοι αναστολεις jak3 kai/ή jak1
CL2015002113A1 (es) Compuestos de azetidinloxifenilpirrolidina
CL2020003015A1 (es) Conversión a escala preparativa de goniautoxinas en neosaxitoxina